Clinical trial
Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications
NCT07106463 is registered in ClinicalTrials.gov with University of Messina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications
- Lead sponsor
- University of Messina
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 30, 2024
- Completion date
- August 29, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, ibd (inflammatory bowel disease)